To Establish the Safety and Effectiveness of the ALPFA GRAIL PFA System for Treating Symptomatic Benign Prostate Hyperplasia (BPH) Also Known as an Enlarged Prostate.
Clinical trial NCT07592299 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07592299
- Sponsor
- ALPFA Medical
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-08-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.